Fig. 2From: Distinct clinical and somatic mutational features of breast tumors with high-, low-, or non-expressing human epidermal growth factor receptor 2 statusHER2 subgroups had different clinical features, including A histological grade, B hormone receptor (HR) expression status, C,D Ki-67 expression levels, and E IHC-based molecular subtype distributionBack to article page